Related Experiment Videos

Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma

Iris Behrmann1, Susanne Wallner, Waraporn Komyod

  • 1Institute of Biochemistry, RWTH-Aachen, Aachen, Germany.

Insights

Methylthioadenosine phosphorylase (MTAP) is frequently inactivated in melanoma, with its loss correlating to tumor progression. This suggests MTAP inactivation plays a key role in melanoma development and may impact interferon sensitivity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant melanoma frequently exhibits homozygous deletions at chromosomal region 9p21.
  • This region harbors tumor suppressor genes p16(INK4a) and p15(INK4b), and also the methylthioadenosine phosphorylase (MTAP) gene.
  • The MTAP gene's location suggests its potential role as a tumor suppressor in melanoma.

Purpose of the Study:

  • To investigate mutations and expression patterns of the MTAP gene in malignant melanomas.
  • To determine the role of MTAP inactivation in melanoma development.

Main Methods:

  • Analysis of 9 human melanoma cell lines and primary melanocytes using reverse transcriptase-polymerase chain reaction (RT-PCR) and sequencing.
  • Immunoblotting to assess MTAP protein expression.
  • Immunohistochemical staining of 38 tissue samples (benign nevi, melanomas, metastases) to evaluate MTAP protein levels in vivo.

Main Results:

  • Significant down-regulation of MTAP mRNA expression was observed in melanoma cell lines.
  • Homozygous deletion of MTAP (exon 2-8) occurred in one cell line; promoter hypermethylation was found in others.
  • A significant inverse correlation was found between MTAP protein expression and melanoma progression, with decreased staining from benign nevi to metastatic melanomas.

Conclusions:

  • MTAP inactivation plays a significant role in the development of melanomas.
  • The observed inverse correlation between MTAP expression and tumor progression highlights its potential as a tumor suppressor.
  • MTAP inactivation may have clinical implications, particularly regarding interferon sensitivity in melanoma patients.

Related Concept Videos